Abstract: This disclosure includes fuel tank fittings, fuel systems and fueling stations having the same, and related methods. Some fuel tank fittings have a first end including a connector configured to be sealingly coupled to an outlet of a fuel tank, wherein the connector has a connection axis, a second end including two or more first ports, each positioned such that the connection axis does not extend therethrough, a first interior passageway extending from the connector, and two or more second interior passageways connecting the first interior passageway to the first ports such that, for each of the first ports, fluid is permitted to flow from the connector, through the first interior passageway, through one or more of the second interior passageways, and out of the first port without flowing through a valve.

Abstract: Some of the present apparatuses include a frame defining first and second supports and at least a portion of a rigid tank mount laterally offset from the first and second supports, where the first support is configured to be pivotally coupled to a vehicle such that the frame is movable relative to the vehicle between a first position in which the second support is spaced apart from the vehicle and second position in which the second support is coupled to the vehicle. Some apparatuses include a frame mount having a flange defining a bounded opening configured to receive a fastener and a post extending from the flange and away from the opening, where the first support is configured to be pivotally coupled to the flange via the fastener and the second support is configured to be coupled to the post when the frame is in the second position.

Abstract: Some of the present apparatuses include a frame defining first and second supports and at least a portion of a rigid tank mount laterally offset from the first and second supports, where the first support is configured to be pivotally coupled to a vehicle such that the frame is movable relative to the vehicle between a first position in which the second support is spaced apart from the vehicle and second position in which the second support is coupled to the vehicle. Some apparatuses include a frame mount having a flange defining a bounded opening configured to receive a fastener and a post extending from the flange and away from the opening, where the first support is configured to be pivotally coupled to the flange via the fastener and the second support is configured to be coupled to the post when the frame is in the second position.

Abstract: Some of the present apparatuses include a frame defining first and second supports and at least a portion of a rigid tank mount laterally offset from the first and second supports, where the first support is configured to be pivotally coupled to a vehicle such that the frame is movable relative to the vehicle between a first position in which the second support is spaced apart from the vehicle and second position in which the second support is coupled to the vehicle. Some apparatuses include a frame mount having a flange defining a bounded opening configured to receive a fastener and a post extending from the flange and away from the opening, where the first support is configured to be pivotally coupled to the flange via the fastener and the second support is configured to be coupled to the post when the frame is in the second position.

Abstract: Some of the present apparatuses include a frame defining first and second supports and at least a portion of a rigid tank mount laterally offset from the first and second supports, where the first support is configured to be pivotally coupled to a vehicle such that the frame is movable relative to the vehicle between a first position in which the second support is spaced apart from the vehicle and second position in which the second support is coupled to the vehicle. Some apparatuses include a frame mount having a flange defining a bounded opening configured to receive a fastener and a post extending from the flange and away from the opening, where the first support is configured to be pivotally coupled to the flange via the fastener and the second support is configured to be coupled to the post when the frame is in the second position.

Abstract: Some of the present apparatuses include a frame defining first and second supports and at least a portion of a rigid tank mount laterally offset from the first and second supports, where the first support is configured to be pivotally coupled to a vehicle such that the frame is movable relative to the vehicle between a first position in which the second support is spaced apart from the vehicle and second position in which the second support is coupled to the vehicle. Some apparatuses include a frame mount having a flange defining a bounded opening configured to receive a fastener and a post extending from the flange and away from the opening, where the first support is configured to be pivotally coupled to the flange via the fastener and the second support is configured to be coupled to the post when the frame is in the second position.

Abstract: The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

Abstract: Compounds of the formula X--Y--R, or the pharmaceutically acceptable salts and esters thereof, wherein X is ##STR1## Y is --SO.sub.2 --, --(CH.sub.2).sub.p -- or --CO--(CH.sub.2).sub.p --; R is unsubstituted or substituted phenyl where said substitutents are one or more of R.sup.5, R.sup.6 or R.sup.7 ; R.sup.1 is hydrogen, cyano, phenyl, --CONHR.sup.2, --CONR.sup.2 R.sup.2, --(CH.sub.2).sub.m --OR.sup.2, --(CH.sub.2).sub.p --S(O).sub.r --R.sup.2, --(CH.sub.2).sub.m --CO.sub.2 R.sup.2, --(CH.sub.2).sub.m --N.sub.3, --(CH.sub.2).sub.m --NH.sub.2 or --(CH.sub.2).sub.m --NR.sup.2 R.sup.2 ; R.sup.2 is hydrogen, C.sub.3-8 cycloalkyl or C.sub.1-5 alkyl; R.sup.5 and R.sup.6 are each independently selected from hydrogen, C.sub.1-5 alkoxy, halogen or --(CH.sub.2).sub.n --N(R.sup.2)--C(O)--R.sup.18 ; R.sup.7 is hydrogen or ##STR2## R.sup.11 is selected from hydrogen, C.sub.1-5 alkyl-carbonyl, --Z--R.sup.13, ##STR3## or substituted C.sub.

Abstract: The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and treatment of cancer, which compound has the structure; ##STR1## or a pharmaceutically acceptable salt or disulfide thereof and wherein the variables are as defined in the specification.

Abstract: The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and treatment of cancer.

Abstract: Compounds of the formula X--Y--R, or the pharmaceutically acceptable salts and esters thereof, wherein X is ##STR1## Y is --SO.sub.2 --, --(CH.sub.2).sub.p -- or --CO--(CH.sub.2).sub.p --; R is unsubstituted or substituted phenyl where said substitutents are one or more of R.sup.5, R.sup.6 or R.sup.7 ; R.sup.1 is hydrogen, cyano, phenyl,--CONHR.sup.2, --CONR.sup.2 R.sup.2, --(CH.sub.2).sub.m --OR.sup.2, --(CH.sub.2).sub.p --S(O).sub.r --R.sup.2, --(CH.sub.2).sub.m --CO.sub.2 R.sup.2, --(CH.sub.2).sub.m --N.sub.3, --(CH.sub.2).sub.m --NH.sub.2 or --(CH.sub.2).sub.m --NR.sup.2 R.sup.2 ; R.sup.2 is hydrogen, C.sub.3-8 cycloalkyl or C.sub.1-5 alkyl; R.sup.5 and R.sup.6 are each independently selected from hydrogen, C.sub.1-5 alkoxy, halogen or --(CH.sub.2).sub.n --N(R.sup.2)--C(O)--R.sup.18 ; R.sup.7 is hydrogen or ##STR2## R.sup.11 is selected from hydrogen, C.sub.1-5 alkylcarbonyl, ##STR3## or substituted C.sub.